Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen

  title={Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen},
  author={J. Prior},
  journal={The Journal of Clinical Endocrinology & Metabolism},
  • J. Prior
  • Published 2019
  • Medicine
  • The Journal of Clinical Endocrinology & Metabolism
  • BACKGROUND Although the 2017 Endocrine Society Guidelines for gender dysphoria stipulated that cross-sex hormone therapy (CHT) achieve gonadal steroid levels equivalent to those of a cisperson of the chosen sex, for transgender women (male-to-female gender dysphoria), current gonadal therapy is usually estradiol. Accumulated evidence indicates that normally ovulatory menstrual cycles are necessary for ciswomen's current fertility, as well as for later-life bone and cardiovascular health and the… CONTINUE READING
    10 Citations
    Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy.
    • 1
    Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
    • 1
    • PDF
    Health considerations for transgender women and remaining unknowns: a narrative review
    • 6
    IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Reaffirmation as Female
    • 1
    Progesterone – Friend or foe?
    • 1


    Oestrogen and anti-androgen therapy for transgender women.
    • 52
    Clinical review: Breast development in trans women receiving cross-sex hormones.
    • 60
    Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy
    • 70
    Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons.
    • 10
    Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study
    • 24
    • PDF
    Progesterone for treatment of symptomatic menopausal women
    • J. Prior
    • Medicine
    • Climacteric : the journal of the International Menopause Society
    • 2018
    • 9
    Endocrine Treatment of Gender‐Dysphoric/Gender‐Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
    • 270
    • PDF